🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn about treatment for a type of b...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-12
Trial ID
NCT06012929
Treatments Being Tested
This phase I trial studies the long-term side effects of the continuation o...
Status
Completed
Location
Rutgers Cancer Institute of New Jersey
Start Date
2015-02-20
Trial ID
NCT02324621
Treatments Being Tested
This study will determine the maximum tolerated dose (MTD) and/or the recom...
Status
Completed
Location
Fox Chase Cancer Center - Philadelphia
Start Date
2015-11-05
Trial ID
NCT02609230
Treatments Being Tested
This is an intermediate-size expanded access protocol to provide ONC201 (do...
Status
Approved For Marketing
Location
BMDACC at Banner University Medical Center Phoenix
Start Date
TBD
Trial ID
NCT04617002
Treatments Being Tested
This was a Phase 1/2 open-label study of ONC201 administered orally once ev...
Status
Terminated
Location
The Mount Sinai Medical Center
Start Date
2017-04-19
Trial ID
NCT02863991
Treatments Being Tested
ONC201 is a small molecule which selectively targets the G protein-coupled ...
Status
Terminated
Location
Fox Chase Cancer Center
Start Date
2017-06-08
Trial ID
NCT03099499
Treatments Being Tested
This is a single arm Phase Ib/II, open label, safety, pharmacokinetic, phar...
Status
Terminated
Location
Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals
Start Date
2019-11-15
Trial ID
NCT03791398
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group, int...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2023-01-23
Trial ID
NCT05580562
Treatments Being Tested
The objective of this expanded access program is to provide ONC201 to eligi...
Status
No Longer Available
Location
Oncoceutics
Start Date
TBD
Trial ID
NCT03134131
Treatments Being Tested
The purpose of this study is to learn if a new drug, ONC201 can make tumors...
Status
Completed
Location
Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2017-08-02
Trial ID
NCT03034200
Treatments Being Tested